Neuren shares soar as Daybue sales surge and royalty guidance jumps on US$35M milestone

Neuren Pharmaceuticals shares soared as Daybue sales surged and royalty guidance jumped on a US$35 million milestone.

Detected & updated continuously · Source: Nebula